GLAXO RETRACTS RANITIDINE CASE

Article Abstract:

Glaxo (India) has taken back the writ petition filed at the Mumbai High Court challenging the reduction in prices of anti- ulcerate ranitidine. Sources say that the company is planning to petition the ministry of chemicals as it was not satisfied of the dilatory court process. The price of the bulk drug was reduced to Rs1203 per kg from Rs1714 per kg. The company's Zinetac formulation of ranitidine has sales of Rs70 crore and accounts for almost 10 percent of the company's total sales. (khr)

Financial management, Antiulcer Preps ex Antacids, Antiulcer agents, Glaxo India Ltd.

---

ZANDU PHARMA IN REVAMP MODE

Article Abstract:

Zandu Pharmaceuticals has engaged the services of A F Ferguson for restructuring of its business. It is a family managed company and this is the first time it has sought professional help from management consultants. Ferguson has recommended setting up of three strategic business units. The company is planning a foray into herbal cosmetics and toiletries. (rk)

Comment:

Zandu Pharmaceuticals has engaged the services of A F Ferguson for restructuring of its business.

New orders received, Pharmaceutical Preparations, Financial Management, Drugs, Zandu Pharmaceuticals, A F Ferguson

---

Similar abstracts:

• Abstracts: CAREW PHARMA FACES LIQUIDITY CRISIS J&J PHARMA DEVELOPMENT HUB TO COME UP IN MUMBAI
• Abstracts: SUNDARAM FINANCE LIMITED ICRA ASSIGNS MAAA TO SUNDARAM FIN DEBENTURE
• Abstracts: AUROBINDO PHARMA LTD: FINANCIAL RESULTS. AUROBINDO PHARMA
• Abstracts: LIC LIFE FUND CROSSES Rs1 LAKH CR LIC (SOUTH) FIRST PREMIUM INCOME RISES BY 30%. SOUTH CENTRAL LIC POSTS 4.6% GROWTH IN POLICIES
• Abstracts: BACK TO NATURE H1 SPICES EXPORTS DOWN 14% IN $-VALUE TERMS. SAFFRON SINKS

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.